Author

M. Cadena

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

C. M. Vezina· 2 shared H. M. Ruetten· 2 shared A. Jain· 1 shared B. Chelgren· 1 shared B. Mueller· 1 shared C. A. O'Driscoll· 1 shared D. E. Bjorling· 1 shared E. Ruoslahti· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 26 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

C. M. Vezina

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

OSTEOPONTIN DEFICIENCY LEADS TO THE RESOLUTION OF PROSTATIC FIBROSIS AND INFLAMMATION

P. Popovics, A. Jain, K. O. Skalitzky, E. Schroeder, H. M. Ruetten, M. Cadena, K. S. Uchtmann, C. M. Vezina, W. A. Ricke

This study shows that OPN deficiency reduces inflammation and fibrosis in the prostate after E. coli infection in mice.

bioRxiv · Jul 19, 2021 · PreprintPathology

A Uropathogenic E. coli UTI89 model of prostatic inflammation and collagen accumulation for use in studying aberrant collagen production in the prostate

H. M. RUETTEN, J. Sandhu, B. Mueller, P. Wang, H. L. Zhang, K. A. Wegner, M. Cadena, S. Sandhu, L. Abler, J. Zhu, C. A. O'Driscoll, B. Chelgren, Z. Wang, T. Shen, J. Barasch, , C. M. Vezina

This paper develops a mouse model of prostatic inflammation and collagen accumulation using E. coli UTI89 instillations to study aberrant collagen production in the prostate.

bioRxiv · Aug 10, 2020Physiology

Systemic Brain Tumor Delivery of Synthetic Protein Nanoparticles for Glioblastoma Therapy

J. V. Gregory, P. Kadiyala, R. Doherty, M. Cadena, S. Habeel, E. Ruoslahti, P. R. Lowenstein, M. G. Castro, J. Lahann

This study develops synthetic protein nanoparticles for GBM therapy, showing they deliver STAT3i siRNA to tumors, enhance radiation response, and induce immune memory in mice.

bioRxiv · Jan 9, 2020Bioengineering